Kristian G. Andersen
@kgandersen.bsky.social
Infectious diseases & genomics. Immunologist in (voluntary) exile. Minimal sarcasm. Fierce HOA (Hater of Acronyms). Personal account - opinions expressed are my own and not those of my employer.
Always hoping for comments and insights - whether the questions are rhetorical or not 😉
February 6, 2026 at 11:31 PM
Always hoping for comments and insights - whether the questions are rhetorical or not 😉
That's a pretty interesting graph - pretty insane!
February 6, 2026 at 10:36 PM
That's a pretty interesting graph - pretty insane!
And, importantly, make sure fears of theoretical risks don't impede our ability to counter existing risks. In terms of importance H5N1 2.3.4.4b in cattle >>>>> AI MooFlu™.
A framework like that described in the article, would completely stop research on those existing pandemic threats.
A framework like that described in the article, would completely stop research on those existing pandemic threats.
February 6, 2026 at 10:35 PM
And, importantly, make sure fears of theoretical risks don't impede our ability to counter existing risks. In terms of importance H5N1 2.3.4.4b in cattle >>>>> AI MooFlu™.
A framework like that described in the article, would completely stop research on those existing pandemic threats.
A framework like that described in the article, would completely stop research on those existing pandemic threats.
This has "OMG MIRROR LIFE 😱" and 'OMG CHATBOXES WILL LEARN ALL OF VIROLOGY AND AI BIOWEAPONS WILL KILL US ALL 😱😱😱" written all over it.
Interesting topic - that we're trying to do some work in too - however, why is it that theoretical risks always take all focus away from real ones?
Interesting topic - that we're trying to do some work in too - however, why is it that theoretical risks always take all focus away from real ones?
February 6, 2026 at 10:35 PM
This has "OMG MIRROR LIFE 😱" and 'OMG CHATBOXES WILL LEARN ALL OF VIROLOGY AND AI BIOWEAPONS WILL KILL US ALL 😱😱😱" written all over it.
Interesting topic - that we're trying to do some work in too - however, why is it that theoretical risks always take all focus away from real ones?
Interesting topic - that we're trying to do some work in too - however, why is it that theoretical risks always take all focus away from real ones?
It's a bit of a shock (the good kind) when you visit Norway - I guess that's what a $2 trillion sovereign wealth fund gets you. Built on oil, no less 😆.
What's also a shock, is the fact that many of the new cars are Chinese and not from legacy brands.
What's also a shock, is the fact that many of the new cars are Chinese and not from legacy brands.
February 6, 2026 at 10:05 PM
It's a bit of a shock (the good kind) when you visit Norway - I guess that's what a $2 trillion sovereign wealth fund gets you. Built on oil, no less 😆.
What's also a shock, is the fact that many of the new cars are Chinese and not from legacy brands.
What's also a shock, is the fact that many of the new cars are Chinese and not from legacy brands.
My old Treg days with CD25 being such a great marker in mice, but an absolute bugger in humans.
February 6, 2026 at 1:39 AM
My old Treg days with CD25 being such a great marker in mice, but an absolute bugger in humans.
CD25 is the bane of my existence.
February 6, 2026 at 12:43 AM
CD25 is the bane of my existence.
I say that, but I'm full of 💩 - I used to keep my primary T cells alive using IL-7... Oh well, I'm more then fighting kind than the supporting one, so IL-2 and IL-17 it is! 💪🔥
February 6, 2026 at 12:42 AM
I say that, but I'm full of 💩 - I used to keep my primary T cells alive using IL-7... Oh well, I'm more then fighting kind than the supporting one, so IL-2 and IL-17 it is! 💪🔥
Never heard of IL-7 - probably wasn't a thing when I was a grad students (i.e., back when I was an actual immunologist..).
IL-2 is the OG to me and I like the Yin and Yang of IL-2 and IL-10 ☯️.
IL-2 is the OG to me and I like the Yin and Yang of IL-2 and IL-10 ☯️.
February 6, 2026 at 12:37 AM
Never heard of IL-7 - probably wasn't a thing when I was a grad students (i.e., back when I was an actual immunologist..).
IL-2 is the OG to me and I like the Yin and Yang of IL-2 and IL-10 ☯️.
IL-2 is the OG to me and I like the Yin and Yang of IL-2 and IL-10 ☯️.
IL-17 is indeed the devil incarnate - which is why I like it... 😈
February 6, 2026 at 12:13 AM
IL-17 is indeed the devil incarnate - which is why I like it... 😈
Come on man - those are weak sauce!!!
IL-2 and IL-17 is where it’s at - up for a fight!
IL-2 and IL-17 is where it’s at - up for a fight!
February 5, 2026 at 11:56 PM
Come on man - those are weak sauce!!!
IL-2 and IL-17 is where it’s at - up for a fight!
IL-2 and IL-17 is where it’s at - up for a fight!
Several of the key points appear incorrect:
"Maintains current policy on funding for international NIH grantees" > No, grants can no longer have foreign subs, obliterating international collaborations.
"Prohibits forward funding of multiyear NIH grants" > It does not - it freezes at 2025 level.
"Maintains current policy on funding for international NIH grantees" > No, grants can no longer have foreign subs, obliterating international collaborations.
"Prohibits forward funding of multiyear NIH grants" > It does not - it freezes at 2025 level.
February 4, 2026 at 3:32 PM
Several of the key points appear incorrect:
"Maintains current policy on funding for international NIH grantees" > No, grants can no longer have foreign subs, obliterating international collaborations.
"Prohibits forward funding of multiyear NIH grants" > It does not - it freezes at 2025 level.
"Maintains current policy on funding for international NIH grantees" > No, grants can no longer have foreign subs, obliterating international collaborations.
"Prohibits forward funding of multiyear NIH grants" > It does not - it freezes at 2025 level.
Totally agree!
The Iiiitalians ain’t got nothin’ on that.
The Iiiitalians ain’t got nothin’ on that.
February 3, 2026 at 2:46 PM
Totally agree!
The Iiiitalians ain’t got nothin’ on that.
The Iiiitalians ain’t got nothin’ on that.